Lotus Pharmaceutical Co., Ltd.

TWSE:1795.TW

271 (TWD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) TWD.

202320222021202020192018201720162015201420132012201120102009
Omzet 16,957.97114,632.77212,649.18910,728.5839,174.746,428.8946,423.765,902.5665,521.9372,310.021658.481503.153532.209590.184606.822
Kosten van de omzet 8,618.9286,826.6237,009.0696,131.964,926.8693,289.4143,344.0862,574.5372,293.1491,155.215249.399228.216204.711235.66248.426
Brutowinst 8,339.0437,806.1495,640.124,596.6234,247.8713,139.483,079.6743,328.0293,228.7881,154.806409.082274.937327.498354.524358.396
Brutowinstmarge 0.4920.5330.4460.4280.4630.4880.4790.5640.5850.50.6210.5460.6150.6010.591
Onderzoek- en ontwikkelingskosten 720.826520.449595.925505.379553.569324.936329.523452.175298.721131.973190.227231.932237.91796.79893.908
Algemene en administratieve kosten 1,224.0681,053.255905.783904.969787.073681.609680.452726.739637.6551,230.571.30168.94152.74761.59451.909
Verkoop- en marketingkosten 2,540.0132,124.6651,808.7481,574.2761,793.6091,684.2471,546.611,904.7321,843.573227.584172.845177.472182.699173.37172.204
Verkoop-, algemene en administratieve kosten 2,715.2753,177.922,714.5312,479.2452,580.6822,365.8562,227.0622,631.4712,481.2281,458.084244.146246.413235.446234.964224.113
Overige kosten 725.832208.05-133.91317.811102.76734.741-52.52952.864214.875-64.76653.93426.01162.01117.904-12.614
Bedrijfskosten 3,436.1013,698.3693,310.4562,984.6243,134.2512,690.7922,556.5853,083.6462,779.9491,590.057434.373478.345473.363331.762318.021
Bedrijfsresultaat 4,902.9424,319.3382,201.0951,637.3511,215.706448.688523.089244.383448.839-435.251-25.291-203.408-145.86522.76240.375
Bedrijfsresultaat ratio 0.2890.2950.1740.1530.1330.070.0810.0410.081-0.188-0.038-0.404-0.2740.0390.067
Totaal overige inkomsten en kosten netto 199.983-379.126-331.076-333.116-339.286-284.984-312.275-225.123-143.972-151.55647.478-5.74113.29612.754-15.178
Inkomen voor belasting 5,102.9253,940.2121,870.0191,304.235876.42163.704210.81419.26304.867-586.80722.187-209.148-32.56935.51625.197
Inkomen voor belasting ratio 0.3010.2690.1480.1220.0960.0250.0330.0030.055-0.2540.034-0.416-0.0610.060.042
Belastingkosten 997.299919.455466.648274.584198.13739.616161.996111.805143.578-42.55910.305-15.9145.83420.46522.08
Nettowinst 4,105.6263,020.7571,403.3711,026.796662.80799.4767.685-134.041103.949-442.12711.882-193.234-38.40315.0513.117
Nettowinstmarge 0.2420.2060.1110.0960.0720.0150.001-0.0230.019-0.1910.018-0.384-0.0720.0260.005
WPA (Winst Per Aandeel) 15.7211.595.54.233.110.420.09-0.560.44-2.41-0.94-4.33-0.820.310.082
Verwaterde WPA 15.6711.545.474.233.110.420.09-0.560.44-2.41-0.94-4.33-0.820.310.082
EBITDA 6,113.5815,256.2042,960.4762,346.9751,802.399875.251833.34603.944961.138-336.89898.92-112.426-34.62768.02752.168
EBITDA ratio 0.3610.3590.2340.2190.1960.1360.130.1020.174-0.1460.15-0.223-0.0650.1150.086